pharmacovigilance

Documents about pharmacovigilance

• Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD)#916246ClinicalTrials.gov
• Pharmacovigilance Data From Digital Health Systems: Regulations, Implications, and Opportunities—A TransCelerate Perspective#153887Springer Nature OA
• Adverse Drug Reactions in Pediatrics: Experience of a Regional Pharmacovigilance Center#842447ClinicalTrials.gov
• The EUROmediCAT Network and Databases: A Resource for Pharmacovigilance in Pregnancy#231766HAL (France)
• Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France#147543HAL (France)
• JAK Inhibitors and Memory Impairment: Disproportionality Analyses in the WHO Global Pharmacovigilance Database, VigiBase#274118HAL (France)
• Critical Appraisal of Artificial Intelligence for Rare-Event Recognition: Principles and Pharmacovigilance Case Studies#299168Springer Nature OA
• Interferon α 2b Pharmacovigilance Study#862075ClinicalTrials.gov
• Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus Group#172254Springer Nature OA
• Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases - An update#178083HAL (France)
• Adverse events of romidepsin versus tucidinostat for peripheral T-cell lymphoma: a pharmacovigilance study using the Japanese adverse drug event report database#223135OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Assessing safety trends of withdrawn medications: A data-driven pharmacovigilance approach using growth models#5267Europe PMC
• High-throughput signal detection of hepatotoxic drug-drug interactions in hospitalized elderly patients: an NLP-driven pharmacovigilance study.#295606PubMed
• Is There a ‘Best’ Way for Patients to Participate in Pharmacovigilance?#113359PhilArchive
• Severe Cutaneous Adverse Reactions Associated With Newer-Generation Antiseizure Medications: A Real-World Pharmacovigilance Study Based on FAERS and JADER#266507Europe PMC
• Pengaruh Vaksin Sinovac terhadap Siklus Menstruasi pada Remaja Perempuan Berbasis Studi Farmakovigilans di Banjarmasin Selatan: Effect of Sinovac Vaccine on Menstrual Cycle in Adolescent Girls Based on Pharmacovigilance Study in South Banjarmasin#1003960Jurnal Surya Medika (JSM)
• Cryptosporidiosis after treatment with fingolimod: a case report and pharmacovigilance review#226830HAL (France)
• Towards Post-Quantum Secure Pharmacovigilance with ML-KEM and ML-DSA#267558arXiv CS
• Impact of the vaccination against SARS-CoV-2 campaign on disproportionality indicator from the WHO pharmacovigilance database: A competition bias study from case/non-case analysis#676855HAL (France)
• Vaccines and the risk of Guillain-Barré syndrome: A French pharmacovigilance analysis#126876HAL (France)
• Ecopharmacovigilance and pharmacovigilance: an analysis of environment-related reporting in VigiBase.#145918NCBI PubMed Central
• A pharmacovigilance study of sirolimus-associated adverse events in organ transplantation.#295231NCBI PubMed Central
• AI for Causality Assessment in Pharmacovigilance: Protocol for a Scoping Review.#421023NCBI PubMed Central
• Guillain–Barré syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance study#676798HAL (France)
• The EUROmediCAT Network and Databases: A Resource for Pharmacovigilance in Pregnancy.#148525NCBI PubMed Central
• A Feasibility Study of Drug–Drug Interaction Signal Detection in Regular Pharmacovigilance#219319Ora Oxford University Research
• CFTR modulators-induced acne: Case series and analysis of pharmacovigilance databases#253987HAL (France)
• A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting#325330ClinicalTrials.gov
• Evaluation of a simplified pharmacovigilance tool for general practitioners: 5 years of insight#676801HAL (France)
• Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system.#122999NCBI PubMed Central
• Pharmacovigilance Data From Digital Health Systems: Regulations, Implications, and Opportunities-A TransCelerate Perspective.#362229NCBI PubMed Central
• Identification of Immunomodulators Associated With Atrial Fibrillation Reporting: Analysis of the WHO Pharmacovigilance Database#633740ClinicalTrials.gov
• Pregabalin-associated adverse drug reactions: A real-world pharmacovigilance study using WHO-VigiAccess.#636405NCBI PubMed Central
• Strengthening pharmacovigilance through patient reporting: a scoping review of awareness, barriers, and facilitators.#9367NCBI PubMed Central
• Strategies and Challenges in Coding Ambiguous Information Using MedDRA®: An Exploration Among Norwegian Pharmacovigilance Officers#219318Ora Oxford University Research
• A comparison of antibiotic resistance reports in pharmacovigilance databases and conventional surveillance across "One Health".#247689NCBI PubMed Central
• Strengthening Pharmacovigilance in Latin America: Multidisciplinary Insights from Two ISoP Latin American Chapter Symposia.#362113NCBI PubMed Central
• Pharmacovigilance Evaluation of Noninfectious Myocarditis and Pericarditis in Immune Checkpoint Inhibitor Recipients Using FAERS.#404376NCBI PubMed Central
• Adverse effects of gender‐affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database#157535HAL (France)
• Early Detection of Absurdity Signals in Pharmacovigilance: A Machine Learning Ensemble Approach to Identify Rare Adverse Drug Reactions#165977bioRxiv / medRxiv
• Analysis signals of disproportionate reporting associated with donanemab: A retrospective pharmacovigilance study using the FAERS database.#288847NCBI PubMed Central
• Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy#894065ClinicalTrials.gov
• Real-world safety assessment of MET-targeted therapies: a pharmacovigilance analysis using the FAERS database.#923372NCBI PubMed Central
• Trends in adverse drug reaction reporting by dentists: a 15-year analysis of German pharmacovigilance data.#143181NCBI PubMed Central
• Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus Group.#182508NCBI PubMed Central
• A 'One Health' cross-sectional analysis of reports of potential antibiotic resistance cases in international pharmacovigilance databases.#280975NCBI PubMed Central
• Detection of drug-induced acute respiratory distress syndrome risk signals in FAERS: a real-world pharmacovigilance study.#315574NCBI PubMed Central
• BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study#676789HAL (France)
• Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databases.#823589NCBI PubMed Central
• cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study#67716ClinicalTrials.gov